专利号:WO-2025120678-A1 优先权日:2023-12-08 标 题 :A process for synthesis of poly-γ-glutamic acid 发明人:DHARNE MAHESH SHANTAPPA; YADAV RAKESHKUMAR JAYNARAYAN 权利人:COUNCIL SCIENT IND RES 摘要:The present invention relates to a field of biopolymers and microbial fermentation. Specifically, the present invention relates to a microbial process for industrial production of a biopolymer. More particularly, the present invention relates to a process for synthesis of poly-γ-glutamic acid from maltose and sugarcane bagasse. The process of the present invention is devoid of pre- treating of raw materials (biomass) thereby eliminating environmental and cost concerns.
专利号:US-2023212621-A1 优先权日:2020-06-09 标题:Process for synthesis of poly-gamma-glutamic acid 发明人:DHARNE MAHESH SHANTAPPA; NAIR PRANAV GIRIJAVALLABHAN 权利人:COUNCIL SCIENT IND RES 摘要:The present invention overcomes the problem of processes yielding poor quantities of poly-gamma-glutamic-acid (γ-PGA) by providing a process and a novel medium for synthesis of γ-PGA in the presence of Bacillus paralicheniformis MCC 196. Wherein, the novel medium comprises tomato waste alone for cost effective and greener production of γ-PGA with yield of 40 g/L. In another process, non-sterile fermentation employs the use of a medium high in sugar content. Wherein, sucrose is used in concentrations up to 50% to obtain more than 280 g/L of poly gamma glutamic acid. The disclosed process is scalable and provides immense economic advantages.
专利号:US-2025304985-A1 优先权日:2022-04-08 标题 :Genetically Engineered Plants for Increased Production of Vindoline 发明人:LEE-PARSONS CAROLYN; COLE LAUREN F 权利人:UNIV NORTHEASTERN 摘要:Two novel transcription factors, CrDELLA1 and CrDELLA2, are described in Catharanthus roseus plants. The DELLA transcription factors have a regulatory role in the synthesis of vinblastine and vincristine, two important anti-cancer compounds that have proved difficult to obtain in sufficient quantities. The present technology provides genetically modified C. roseus plants having enhanced DELLA activity, which leads to activation of multiple enzymes in the biosynthetic pathway leading to vinblastine and vincristine. The genetic modifications can be used together with activation of plant defense mechanisms and responses to light in order to boost vinblastine and vincristine synthesis.
专利号:US-11492445-B2 优先权日:2017-08-30 标 题:Direct synthesis of glycidyl azide polymers 发明人:FENG XIAOSHUANG; BOOPATHI Senthil; HADJICHRISTIDIS NIKOLAOS; GNANOU YVES 权利人:UNIV KING ABDULLAH SCI & TECH 摘要:Embodiments of the present disclosure describe a method of synthesizing a glycidyl azide homopolymer comprising contacting a glycidyl azide monomer, an initiator, and a Lewis acid sufficient to form the glycidyl azide homopolymer; wherein the glycidyl azide homopolymer is directly polymerized from the glycidyl azide monomer. Embodiments of the present disclosure further describe a method of making a glycidyl azide polymer comprising contacting one or more of a glycidyl azide monomer, an epoxide monomer, carbon dioxide, an initiator, and a Lewis acid in a reaction medium to form a glycidyl azide polymer.
专利号:US-12416029-B2 优先权日:2016-06-27 标 题 :Compositions and methods for making benzylisoquinoline alkaloids, morphinan alkaloids, thebaine, and derivatives thereof 发明人:FACCHINI PETER JAMES; CHEN XUE; COLBECK JEFFREY C; TUCKER JOSEPH E 权利人:ANTHEIA INC 摘要:Disclosed herein are methods that may be used for the synthesis of benzylisoquinoline alkaloids (“BIAsâ€?) such as alkaloid morphinan. The methods disclosed can be used to produce thebaine, oripavine, codeine, morphine, oxycodone, hydrocodone, oxymorphone, hydromorphone, naltrexone, naloxone, hydroxycodeinone, neopinone, and/or buprenorphine. Compositions and organisms useful for the synthesis of BIAs, including thebaine synthesis polypeptides, purine permeases, and polynucleotides encoding the same, are provided.
专利号:US-2025075200-A1 优先权日:2022-05-27 标题:Biocatalysts for organic synthesis 发明人:ALVARENGA DA SILVA NATALIA; STRIDFELDT ELIN; VOLKOV ALEXEY; RUGGIERI FEDERICA; HENDIL-FORSSELL PETER; RÄMGÃ…RD CARL; BAUMGARTEN THOMAS; MATTEY ASHLEY; MURPHY VINCE; THOMPSON MATTHEW P; CLEMMENTS ALDEN M; GERGEL SEBASTIAN 权利人:ENGINZYME AB 摘要:The invention relates to a biocatalyst for organic synthesis, comprising a controlled porosity silica (CPS) as support material, wherein the pore diameter is between about 20 and about 100 nm, said support material comprising an amino-functionalized surface; and one or more catalytically active enzyme(s) immobilized on the support material. The invention also relates to uses of such biocatalysts and methods of manufacture thereof.
1: Qi Q, Lu N, Li C, Zhao J, Liu W, You Q, Guo Q. Involvement of RECK in gambogic acid induced anti-invasive effect in A549 human lung carcinoma cells. Mol Carcinog. 2014 Feb 14. doi: 10.1002/mc.22138. [Epub ahead of print] doi: 10.1111/bph.12501. doi: 10.1016/j.freeradbiomed.2013.12.027. Epub 2014 Jan 7. doi: 10.1016/j.tiv.2013.12.008. Epub 2013 Dec 27. doi: 10.1158/1078-0432.CCR-13-1063. Epub 2013 Dec 12. 6: Wang LH, Li Y, Yang SN, Wang FY, Hou Y, Cui W, Chen K, Cao Q, Wang S, Zhang TY, Wang ZZ, Xiao W, Yang JY, Wu CF. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling. Br J Cancer. 2014 Jan 21;110(2):341-52. doi: 10.1038/bjc.2013.752. Epub 2013 Dec 3. 7: Liu N, Huang H, Xu L, Hua X, Li X, Liu S, Yang C, Zhao C, Zhao C, Li S, Dou QP, Liu J. The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo. Toxicol Lett. 2014 Jan 30;224(3):333-40. doi: 10.1016/j.toxlet.2013.11.021. Epub 2013 Nov 26. doi: 10.2147/IJN.S51622. Epub 2013 Sep 30.
合成参考文献
摘要:Zhongliu Yanjiu Cancer Review, Yu, R., et al., eds., Shanghai Science/Technology Publisher,Peop. Rep. China, 1994, -(220), 1994 摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198 摘要:Guo QL, You QD, Wu ZQ, Yuan ST, Zhao L. General gambogic acids inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude mice. Acta Pharmacol Sin. 2004 Jun;25(6):769–74. 参考文献:10.1016/j.celrep.2012.11.023 摘要:Li X, Liu S, Huang H, Liu N, Zhao C, Liao S, Yang C, Liu Y, Zhao C, Li S, Lu X, Liu C, Guan L, Zhao K, Shi X, Song W, Zhou P, Dong X, Guo H, Wen G, Zhang C, Jiang L, Ma N, Li B, Wang S, Tan H, Wang X, Dou QP, Liu J. Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo. Cell Rep. 2013 Jan 31;3(1):211–22. doi: 10.1016/j.celrep.2012.11.023. 摘要:Deschatrette J, Ng-Bonaventure K, Philippe L, Wolfrom C. Interaction between Gambogic acid and dihydrofolate reductase and synergistic lethal effects with methotrexate on hepatoma cells. Anticancer Res. 2013 Jan;33(1):133–42.